阿格列汀联合格列美脲治疗糖尿病大鼠的疗效及对胰岛β细胞功能的影响

Abstract
Figure/Table
References (18)
Related Citation (1)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the hypoglycemic effects and the function of islet β cells of Alogliptin combined with Glimepiride in type 2 diabetes mellitus rats.Methodsfifty rats of type 2 diabetes mellitus which were induced through high-sucrose and high-fat diet combined with low-dose abdominal injection of Streptozotocin were randomly divided into five groups:model group(group A),Alogliptin group(group B),Glimepiride group(group C),Alogliptin combined with Glimepiride group (group D),Alogliptin combined with Glibenclamide (group E),10 rats in each group.Another 10 normal rats were selected as normal group(group F).The fasting blood glucose(FBG),level of plasma insulin(FIns),total cholesterol(TC)and triglyceride(TG)levels were detected in rats after treated for 28 days,the HOMA-βF index and insulin resistance index(HOMA-IR)were calculated.ResultsAfter 28 d treatment,the FBG,TG,TC,Fins and HOMAIR of the rats in group A,B,C,D and E were all higher than those in group F,the HOMA-βF was lower than group F,and the differences were statistically significant(P<0.01).The FBG,TG,TC,FIns,and HOMA-IR of rats in group B,C,D and E were significantly lower than those in group A,and HOMA-βF was higher than group A,and the differences were statistically significant(P<0.01).The FBG and FIns of rats in group C were lower than those in group B,TG and TC were higher than those in group B,the differences were statistically significant(P<0.05).The FBG,TG,TC,Fins and HOMA-IR of rats in group D and E were significantly lower than those of group B,HOMA-βF was higher than group B,and the differences were statistically significant(P<0.01).The FBG,TG,TC,FIns and HOMA-IR of the rats in group D and E were lower than those in group C,HOMA-βF was higher than that in group C,and the differences were statistically significant(P<0.05).There was no statistically significant difference between D and E groups(P>0.05).ConclusionAlogliptin,Glimepiride single or combined can significantly reduce the blood glucose of type 2 diabetic rats,improve TG,TC,the function of islet β cell and insulin resistance,but combined effect is better than single drug therapy.

Key words： Alogliptin;Glimepiride;Type2diabetesmellitus rats;Islet &beta cell function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Jian
	WEN Jian-dong
	XIAO Lin-lin
	XUE Xiao-yan
	DUAN De-zheng

Cite this article:

WU Jian,WEN Jian-dong,XIAO Lin-lin, et al. Effect of Alogliptin combined with Glimepiride in diabetes rats and its influence on islet β cells function[J]. 中国当代医药, 2017, 24(33): 10-12.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I33/10

[1]	邹大进，张征，赵琳.二肽基肽酶-4抑制剂在2型糖尿病伴心血管疾病及高危患者中的应用评价[J].中国糖尿病杂志，2015，23（1）：91-93.
[2]	Yang W，Lu J，Weng J，et al.Prevalence of diabetes among men and women in China[J].N Engl J Med，2010，62（12）：1090-1101.
[3]	邢冬杰，孙永显，陈桂玉，等.杜仲叶黄酮对糖尿病大鼠的血糖控制及对胰岛细胞的保护作用[J].中国实验方剂学杂志，2015，21（13）：148-151.
[4]	马锐，吴胜本，毛静远.生脉注射液联合格列美脲治疗气阴两虚型2型糖尿病的临床疗效及对患者血清炎性因子的影响[J].中国实验方剂学杂志，2016，22（4）：150-153.
[5]	林汉英，谢乃强，伍华.西格列汀联合格列美脲治疗2型糖尿病的疗效观察[J].临床军医杂志，2015，43（8）：800-802.
[6]	刘琼，何翠英，卫家芬.DPP-4抑制剂治2型糖尿病的研究进展及临床应用[J].实用药物与临床，2015，18（7）：856-859.
[7]	李丽艳.沙格列汀联合格列美脲治疗2型糖尿病的疗效分析[J].医学理论与实践，2017，30（10）：1453-1454.
[8]	邵爱萍.格列美脲联合利格列汀治疗2型糖尿病合并肥胖患者的临床效果[J].中国医药导报，2017，14（3）：88-91.
[9]	王瑜，胡明，占美，等.阿格列汀治疗2型糖尿病的系统评价[J].中国医院药学杂志，2014，34（23）：2014-2022.
[10]	Maiti S，Ali KM，Jana K，et al.Ameliorating effect of mother tincture of Syzygiumjambolanum on carbo-hydrateand lipid metabolic disorders in streptozotocin-induceddiabetic rat：Homeopathic remedy[J].Nat Sci Biol Med，2013，4（1）：68-73.
[11]	陈赛贞，徐红燕，林利芬，等.六味地黄丸对大鼠体内格列美脲药动学特征的影响[J].中国临床药学杂志，2016，25（4）：218-221.
[12]	张四青，习燕华，钟树妹，等.甘精胰岛素联合二甲双胍治疗对新诊断2型糖尿病伴非酒精性脂肪肝病患者血糖和胰岛β细胞功能的影响[J].中国当代医药，2015，22（29）：42-44.
[13]	张蕾，柯瑞琼，欧阳灿晖，等.二甲双胍联合格列美脲治疗非酒精性脂肪肝合并2型糖尿病肥胖患者的效果观察[J].2016，23（20）：132-134.
[14]	Scott LJ.Alogliptin：a review of its use in the management of type 2 diabetes mellitus[J].Drugs，2010，70（15）：2051-2072.
[15]	段小云，冯碧敏，张成斌，等.阿格列汀与其他口服降糖药比较治疗2型糖尿病的系统评价[J].中国新药与临床杂志，2017，36（4）：226-233.
[16]	许小平，郑晓华.格列美脲联合胰岛素治疗2型糖尿病的疗效及对胰岛素剂量的影响[J].中国老年学杂志，2013，33（3）：1417-1418.
[17]	柯瑞琼，秦永章，肖丽霞，等.加用格列美脲对单用预混胰岛素治疗2型糖尿病患者血糖漂移的影响[J].中国当代医药，2015，22（33）：91-93，96.
[18]	虞欣.阿格列汀与吡格列酮联合治疗2型糖尿病的疗效及对胰岛β细胞功能改善的影响[J].实用临床医药杂志，2017，21（9）：64-68.